AGF Investments Inc’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-4,226	Closed	-$405K	–	760
2020 Q4	$405K	Sell	4,226 -1,416	-25%	-$136K	﹤0.01%	491
2020 Q3	$543K	Buy	5,642 +3,121	+124%	+$300K	0.01%	433
2020 Q2	$308K	Sell	2,521 -537	-18%	-$65.6K	﹤0.01%	515
2020 Q1	$265K	Buy	+3,058	New	+$265K	﹤0.01%	489